CIM
KITE

CIM Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

CIM Investment Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,101
Closed -$321K – 372
2017
Q2 		$321K Sell
3,101
-99
-3% -$8.08K 0.11% 259
2017
Q1 		$251K Sell
3,200
-3,200
-50% -$198K 0.09% 304
2016
Q4 		$287K Hold
6,400
– – 0.1% 269
2016
Q3 		$358K Buy
6,400
+240
+4% +$13.4K 0.14% 204
2016
Q2 		$308K Buy
6,160
+610
+11% +$30K 0.13% 212
2016
Q1 		$255K Buy
+5,550
New +$269K 0.11% 222
2015
Q4 		– Sell
-5,337
Closed -$297K – 273
2015
Q3 		$297K Buy
5,337
+640
+14% +$40.3K 0.14% 170
2015
Q2 		$286K Buy
+4,697
New +$268K 0.13% 172

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIM Investment Management's KITE Position: Q3 2017 in Review

CIM Investment Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 3,101 shares — an estimated $321K sold.

CIM Investment Management first reported a position in KITE in Q2 2015 and held it in 8 quarters. The position peaked at $358K in Q3 2016. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • CIM Investment Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • CIM Investment Management sold 3,101 Kite Pharma, Inc. shares in Q3 2017, an estimated $321K.
  • CIM Investment Management first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 8 quarters.
  • CIM Investment Management's Kite Pharma, Inc. position peaked at $358K in Q3 2016.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on CIM Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.